43 results on '"Leonel Barreto Gutierrez"'
Search Results
2. Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
3. PSP is a promising biomarker of sepsis; however, potential elimination by RRT must be considered
4. Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure
5. Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
6. Inhibiting IL-6 in COVID-19: we are not sure
7. Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?
8. Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension
9. Membrane adsorption in vancomycin treatment is membrane type dependent in CVVHDF: dose correction is crucial
10. Study find that COVID ARDS was associated with a low risk for possible or proven PCP: still true after dexamethasone use
11. Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
12. Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID
13. Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
14. Indirect calorimetry is the gold standard to assess REE in ICU patients: some limitations to consider
15. Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies
16. Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
17. SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy
18. A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone: true effect or mediated by a negative fluid balance achieved by RRT?
19. Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
20. Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!
21. TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
22. Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?
23. Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
24. Patients with emm1/T1 serotype invasive group A streptococci infections demonstrated more renal failure than patients with other serotypes: perhaps we should consider some confounders
25. Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy
26. Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation
27. Early latency evoked potentials can no longer be considered an infallible predictor of neurologic outcome
28. Using indirect calorimetry in place of fixed energy prescription was feasible and energy targets were more closely met: do not forget an important limitation
29. Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
30. Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
31. Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
32. Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
33. How levosimendan can improve renal function?
34. Obesity inducing acute respiratory distress syndrome: we should choose the right population!
35. What should be the best dialysis catheter lock in critically ill patients?
36. Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
37. Endotoxin removal by polymyxin B: is it a question of dose or duration or both?
38. Icatibant, another piece of the therapeutic puzzle regarding hemodynamic side effects of angiotensin-converting enzyme inhibitors
39. Is cortical perfusion a reliable marker for predicting septic acute kidney injury?
40. Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
41. Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders
42. Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
43. Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.